Preparation, Characterization, and Evaluation of Curcumin-Graphene Oxide Complex-Loaded Liposomes against
Journal
ACS omega
ISSN: 2470-1343
Titre abrégé: ACS Omega
Pays: United States
ID NLM: 101691658
Informations de publication
Date de publication:
06 Dec 2022
06 Dec 2022
Historique:
received:
23
06
2022
accepted:
17
10
2022
entrez:
12
12
2022
pubmed:
13
12
2022
medline:
13
12
2022
Statut:
epublish
Résumé
This study describes the development and characterization of curcumin with graphene oxide complex (CUR + GO) loaded into liposomes for treating skin disease. The developed complex was characterized by X-ray diffraction and showed a broad halo pattern, confirming the amorphous nature of the resulting complex. Furthermore, scanning electron microscopy revealed the irregular porous morphology of the complex-highlighting loss of the crystallinity and the emergence of the amorphous phase. Additionally, the liposomes showed long-term stability at 2-8 °C and 25 ± 2 °C/60 ± 5%RH with nonsignificant variations in the particle size, polydispersity index, and zeta potential. Overall, optical and high-resolution transmission electron microscopy images of liposomes showed a consistent shape, and no aggregation with uniform particle size distribution was observed. Furthermore, the cumulative drug release in the first 6 h was 71.24 and 64.24% for CUR-loaded liposomes and CUR-GO-loaded liposomes, respectively. The lower value of drug release might be attributed to the complex development. The drug release model found the first order with non-Fickian diffusion process, which is often observed at higher
Identifiants
pubmed: 36506117
doi: 10.1021/acsomega.2c03940
pmc: PMC9730485
doi:
Types de publication
Journal Article
Langues
eng
Pagination
43499-43509Informations de copyright
© 2022 The Authors. Published by American Chemical Society.
Déclaration de conflit d'intérêts
The authors declare no competing financial interest.
Références
Int J Nanomedicine. 2020 May 01;15:3099-3120
pubmed: 32431504
Food Chem. 2020 Oct 1;326:126973
pubmed: 32413757
Eur J Drug Metab Pharmacokinet. 2019 Aug;44(4):459-480
pubmed: 30771095
Antimicrob Agents Chemother. 2021 Mar 18;65(4):
pubmed: 33468460
Cell Mol Biol (Noisy-le-grand). 2022 Feb 04;67(5):151-156
pubmed: 35818258
Phys Chem Chem Phys. 2019 Jul 17;21(28):15504-15514
pubmed: 31259324
Drug Deliv. 2021 Dec;28(1):1972-1981
pubmed: 34565260
Prim Care. 2018 Sep;45(3):433-454
pubmed: 30115333
Expert Rev Pharmacoecon Outcomes Res. 2018 Jun;18(3):235-244
pubmed: 29521147
J Phys Chem A. 2022 Mar 17;126(10):1591-1604
pubmed: 35239351
Antibiotics (Basel). 2022 Feb 28;11(3):
pubmed: 35326785
Materials (Basel). 2021 Apr 30;14(9):
pubmed: 33946613
RSC Adv. 2020 Sep 1;10(54):32409-32422
pubmed: 35685615
Mater Sci Eng C Mater Biol Appl. 2021 Apr;123:111934
pubmed: 33812573
Recent Pat Antiinfect Drug Discov. 2019;14(1):3-4
pubmed: 31722657
Foods. 2022 May 18;11(10):
pubmed: 35627039
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S1186-S1192
pubmed: 30688100
Drug Dev Ind Pharm. 2019 Mar;45(3):395-404
pubmed: 30442066
Int J Pharm. 2020 Apr 30;580:119183
pubmed: 32112930
Colloids Surf B Biointerfaces. 2021 Apr;200:111617
pubmed: 33592455
ACS Omega. 2022 Mar 10;7(11):9452-9464
pubmed: 35350323
Gels. 2022 Feb 18;8(2):
pubmed: 35200513
Crit Rev Anal Chem. 2022;52(2):392-412
pubmed: 32799645
Int J Biol Macromol. 2020 Dec 1;164:1370-1383
pubmed: 32735925
ACS Appl Bio Mater. 2020 Sep 21;3(9):6284-6296
pubmed: 35021759
Biotechnol Lett. 2020 Dec;42(12):2653-2664
pubmed: 32683522
RSC Adv. 2022 Jul 4;12(30):19375-19383
pubmed: 35865592
IET Nanobiotechnol. 2021 Feb;15(1):79-89
pubmed: 34694731
Nanomaterials (Basel). 2020 Feb 21;10(2):
pubmed: 32098083
Spectrochim Acta A Mol Biomol Spectrosc. 2020 Jan 5;224:117392
pubmed: 31330421
Nanomedicine (Lond). 2015;10(15):2405-22
pubmed: 26252175
Int J Pharm. 2021 Jun 1;602:120628
pubmed: 33892061